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ABSTRACT The mixing of mitochondrial DNA (mtDNA) from the donor cell and the recipient oocyte in
embryos and offspring derived from somatic cell nuclear transfer (SCNT) compromises genetic integrity and
affects embryo development. We set out to generate SCNT embryos that inherited their mtDNA from the
recipient oocyte only, as is the case following natural conception. While SCNT blastocysts produced from
Holstein (Bos taurus) fibroblasts were depleted of their mtDNA, and oocytes derived from Angus (Bos
taurus) cattle possessed oocyte mtDNA only, the coexistence of donor cell and oocyte mtDNA resulted
in blastocysts derived from nondepleted cells. Moreover, the use of the reprogramming agent, Trichostatin
A (TSA), further improved the development of embryos derived from depleted cells. RNA-seq analysis
highlighted 35 differentially expressed genes from the comparison between blastocysts generated from
nondepleted cells and blastocysts from depleted cells, both in the presence of TSA. The only differences
between these two sets of embryos were the presence of donor cell mtDNA, and a significantly higher
mtDNA copy number for embryos derived from nondepleted cells. Furthermore, the use of TSA on embryos
derived from depleted cells positively modulated the expression of CLDN8, TMEM38A, and FREM1, which
affect embryonic development. In conclusion, SCNT embryos produced by mtDNA depleted donor cells
have the same potential to develop to the blastocyst stage without the presumed damaging effect resulting










Assisted reproductive technologies, such as somatic cell nuclear transfer
(SCNT), offer the potential to produce animals with enhanced genetic
qualities by combining favorable chromosomal traits with favorable
mitochondrial DNA (mtDNA) traits. During SCNT, a somatic donor
cell is transferred into an enucleated recipient oocyte. Reconstructed
oocytes are then activated chemically and cultured for 7 d to the blas-
tocyst stage. The blastocyst is transferred to a recipient and an offspring
is delivered (Wilmut et al. 1997). However, the overall efficiency of
SCNT in domestic species is still low (reviewed by Keefer 2015), which
is thought to be caused by incomplete epigenetic reprogramming
(Jaenisch et al. 2002). For example, aberrant DNA methylation, histone
methylation, and histone acetylation patterns have been identified at
greater frequencies in SCNT cattle embryos when compared with
in vivo or in vitro fertilized embryos (Bourc’his et al. 2001; Kang et al.
2002; Dean et al. 2003; Han et al. 2003; Santos et al. 2003). Consequently,
Trichostatin A (TSA), a histone deacetylase inhibitor, has been widely
used for enhancing SCNT efficiency in mouse (Kishigami et al. 2006;
Rybouchkin et al. 2006), cattle (Akagi et al. 2011; Lee et al. 2011;
Srirattana et al. 2012), pigs (Zhang et al. 2007; Li et al. 2008; Kim et al.
2011), rabbits (Shi et al. 2008), and sheep (Hu et al. 2012).
Nevertheless, there are still a numberof confounding issues related to
SCNT, especially the irregular patterns of transmission of the mito-
chondrial genome.MtDNAis a circular, double-strandedmolecule that,
in cattle, is 16.3 kb in size (Anderson et al. 1982). It encodes 13
protein-coding genes of the electron transfer chain that mediates the
process of oxidative phosphorylation (Anderson et al. 1982), 22 tRNAs,
and two rRNAs. It also has one noncoding region, the D-loop, which
houses the control region, and two hypervariable regions.
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MtDNA is normallymaternally-only inherited (Birky 1995), and, as a
result, a uniformpopulation ofmtDNA is transmitted through the female
germ line fromone generation to the next. In SCNT, as awhole donor cell
is transferred into an enucleated oocyte, not only is the nuclear genome
passed onto the oocyte, but also themtDNA present in the mitochondria
surrounding the donor cell (Takeda et al. 2003).Donor cells typically have
between 0.5 and 8 · 102 copies of mtDNA per cell (Burgstaller et al.
2007; Jiang et al. 2011), while cattle oocytes have between 3 and 6 · 105
copies of mtDNA (May-Panloup et al. 2005; Iwata et al. 2011; Cree et al.
2015). As a result, two genetically diverse populations of mtDNA can
coexist within the embryo, and, as mtDNA is prematurely replicated in
SCNT-derived preimplantation embryos (Bowles et al. 2007), its pres-
ence is not just dependent on the amount of donor cell mtDNA that is
introduced into the recipient oocyte (reviewed in St. John et al. 2010).
Indeed, the transmission of donor cell mtDNA is a random event, with
donor cell mtDNA contributing from 0 to 59% of the offspring’s total
mtDNA content in livestock species (Steinborn et al. 2002; Hiendleder
et al. 2003; Takeda et al. 2003). Furthermore, in mouse models, it is well
documented that two genetically distinct populations ofmtDNAcan lead
to severe metabolic syndromes and other disorders (Nakada et al. 2001;
Acton et al. 2007). Many of these disorders are similar to those reported
in SCNT animals (Cibelli et al. 2002). However, it is not only the mixing
of donor cell and oocyte mtDNA that could lead to developmental
abnormalities, but the donor cell could be contributing aged and dam-
aged mitochondria to the oocyte, which could trigger processes such as
apoptosis in the developing embryo (Li et al. 2000; Zhao et al. 2015), and
lead to the occurrence of late-onset disease. Likewise, mitochondria iso-
lated from somatic cells are metabolically more active (Takeda et al.
2010), which could be detrimental to early developmental outcomes.
One way to ensure that SCNT offspring inherit only oocytemtDNA
is to deplete the donor cell of its mtDNA prior to SCNT. This could be
achieved by using DNA depletion agents such as ethidium bromide
(Desjardins et al. 1985; Hayakawa et al. 1998; Lloyd et al. 2006; Lee et al.
2010) or 29-39 dideoxycytidine (ddC) (Brinkman and Kakuda 2000).
They act by inhibiting the nuclear-encoded mtDNA-specific DNA
Polymerase, DNA Polymerase Gamma (POLG), from interacting with
the mitochondrial genome. Indeed, ddC is specific to POLG as it does
not affect the polymerases that drive replication of nuclear DNA (e.g.,
DNA polymerase alpha, delta, and epsilon; reviewed by Brinkman et al.
1998). Consequently, as mtDNA replication does not take place, the
mtDNA content of the cell is diluted out with each cell division while in
culture (Brinkman et al. 1999).
Here, we show that mtDNA-depleted cells can be used to generate
viable blastocysts. When the reconstructed oocytes were cultured in the
presence of TSA, they had increased development rates to the blastocyst
stage. Furthermore, blastocysts derived from mtDNA-depleted cells
were able to efficiently regulate their mtDNA copy number, and they
exhibited different chromosomal gene expression profiles to blastocysts
generated from nondepleted cells.
MATERIALS AND METHODS
All chemicals and reagents were purchased from Sigma-Aldrich (St.
Louis, MO) unless otherwise specified.
Donor cell preparation
Skin fibroblasts were obtained from an adult cow (Holstein No. 1, Bos
taurus). Donor cell mtDNA was depleted from cattle fibroblasts by
culturing the cells in Dulbecco’s Modified Eagle Medium (DMEM,
Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum
(FBS, Gibco, batch number 1153562), in the presence of 20 mM 29-39-
dideoxycytidine (ddC) and 50 mg/ml uridine at 37 under humidified
atmosphere of 5% CO2 in air for 30 d (mtDNA depleted cell). To
determine whether mtDNA copy number could recover following
mtDNA depletion, depleted cells were continuously cultured in the
absence of ddC for 14 d.
Prior to SCNT, mtDNA-depleted cells were harvested by standard
trypsinization with TrypLE Express (Gibco), and resuspended in
EMCARE holding solution (ICPbio Reproduction, Timru, Auckland,
New Zealand). For nondepleted cells, fibroblast cells were synchronized
to theG0/G1phasebyculture inDMEMsupplementedwith0.5%FBSat
37 under humidified atmosphere of 5% CO2 in air for 2–3 d.
SCNT embryo production
To evaluate the effects of depletingmtDNA from the donor cells andTSA
supplementation on the developmental potential of SCNT embryos,
four different groups of embryos were produced: (1) embryos derived
from nondepleted cells in the absence of TSA; (2) embryos derived
from nondepleted cells in the presence of TSA; (3) embryos derived from
depleted cells in the absence of TSA; and (4) embryos derived from
depleted cells in the presence of TSA.
Oocyte preparation and SCNT were performed as previously de-
scribed (Srirattana et al. 2012). Briefly, cumulus oocyte complexes
(COCs) were aspirated from follicles of 2–3 mm from abattoir-derived
ovaries (Angus, B. taurus). Then, the COCs were cultured in IVM me-
dium [TCM199 supplemented with 10% FBS, 50 IU/ml hCG (Chorulon,
Intervet, Bendigo East, VIC, Australia), 0.5 mg/ml FSH (Folltropin-V,
Bioniche Animal Health, Belleville, ON, Canada), 1 mg/ml 17b-estradiol]
at 38.5 under humidified atmosphere of 5% CO2 in air for 19 hr.
Cumulus cells were then removed from COCs by repeated pipetting in
0.2%hyaluronidase. Enucleationwas performed in 5 mg/ml cytochalasin
B by aspirating the spindle from metaphase II (MII) oocytes using a
micropipette (OD 12 mm, ID 9 mm, The Pipette Company, Adelaide,
SA, Australia) under theOosight Imaging System (CRi,Woburn,MA). A
single donor cell from mtDNA-depleted cells (passage number 11) or
nondepleted cells (passage number 9) was then inserted into the peri-
vitelline space of each enucleated oocyte. The donor cell–cytoplast cou-
plets were fused in Zimmermann fusion media (Zimmermann and
Vienken 1982) using two direct current pulses of 22 V and 14 ms gen-
erated by a BTX Electro Cell Manipulator 200 (BTX, San Diego, CA).
Reconstructed oocytes were separated into two groups (absence of
TSA, and presence of TSA). For the absence of TSA group, the recon-
structed oocytes were placed in EMCARE holding solution for 1 hr, and,
then, the success of the fusion was determined. The successfully fused
oocytes were activated using 7% ethanol for 5 min at room temperature
followed by 1.25 mg/ml cytochalasin D, and 10 mg/ml cycloheximide at
38.5 under humidified atmosphere of 5% CO2, 5% O2 and 90% N2 for
5 hr. After activation, the embryos were cultured in CR1aa medium
(Rosenkrans et al. 1993) at 38.5 under humidified atmosphere of 5%
CO2, 5% O2 and 90% N2 for 7 d. A half volume of CR1aa medium was
replaced at days 3 and 5 of culture. In the presence of TSA, just minutes
after fusion, reconstructed oocytes were placed in EMCARE holding
solution supplemented with 50 nM TSA for 1 hr. Successfully fused
oocytes were activated and cultured in medium supplemented with
TSA for up to 10 hr (Srirattana et al. 2012). After that, embryos were
continuously cultured in the medium without TSA for 7 d until they
reached the blastocyst stage. A half volume of CR1aa medium was
replaced at days 3 and 5 of culture. All experiments were run in parallel.
Assessment of cell number of SCNT embryos
After 7 d of culture, SCNT embryos at the blastocyst stage (three
individual embryos per group) were fixed with 4% paraformaldehyde,
permeabilized in 0.1%Triton X-100, and then stainedwith 10 ml/ml of
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Hoechst 33258. The stained blastocysts were visualized using an
inverted confocal microscope (FV1200, Olympus, Tokyo, Japan). The
number of cells were determined by counting the number of Hoechst
stained nuclei.
MtDNA copy number analysis
Total DNA was extracted frommtDNA-depleted cells at various stages
of depletion and recovery using the ISOLATE II Genomic DNA Kit
(Bioline,Alexandria,NSW,Australia), and fromoocytes at theMII stage
and embryos at the blastocyst stage (10 individual oocytes/embryos per
group) using the QIAampDNAMicro Kit (Qiagen, Hilden, Germany),
according to the manufacturer’s instructions.
Primers for assessingmtDNA copy number were designed from the
cytochromeB (CYTB) region and theNADHdehydrogenase subunit 2
(ND2) region. For depleted cells, diploid nuclear genome analysis was
also performed using the primers designed from the POU domain, class
5 transcription factor 1 (POU) region. Primer sequences are listed in
Supplemental Material, Table S1 in File S4.
The mitochondrial and nuclear DNA target sequences were quan-
tified by real-time polymerase chain reaction (PCR) using a Rotorgene
3000 real-timemachine (Corbett Life Science, Sydney,NSW,Australia).
The quantification of mtDNAwas performed in 20 ml volumes of PCR
mixtures containing 1· SensiMix SYBRHi-ROX (Bioline), 0.25 mMof
each primer, as listed in Table S1, and 20 ng of depleted cell DNA or
2 ml of embryo DNA. PCR amplification was carried out at 95 for
15 min, followed by 45 cycles of 95 for 15 sec, 58 (for CYTB) or 55
(for ND2) or 59 (for POU) for 15 sec, and 72 for 15 sec. The final
elongation step was performed at 72 for 15 sec. The fluorescence
signal was obtained via the FAM/Sybr channel at the elongation phase.
From the first fluorescence signals, melting curve data were generated
by heating PCR products from 47–98, holding for 4 sec at each step.
These data were used to determine the second extension phase, which
was set at the temperature just before the start of themelt curve phase to
exclude the negative effects of primer-dimerization. The second exten-
sion phase was set at 78 for CYTB, or 74 for ND2, and 80 (for POU)
for 15 sec, and the second fluorescence signals were acquired.
To generate standards for real-time PCR, the CYTB,ND2, and POU
regions were amplified from total DNA obtained from nondepleted
cells. The PCR products were purified using the Isolate II PCR Gel
Kit (Bioline), according to the manufacturer’s instructions, and were
used as standards. For each run, a standard curve was generated from
10-fold serial dilutions (1021 –1028). mtDNA copy number per cell
was calculated from the number of CYTB and ND2 copies, and each
divided by half the number ofPOU copies. Each samplewas analyzed in
triplicate to obtain the mean number of mtDNA copies.
Analysis of the persistence of donor cell mtDNA in
SCNT embryos
To determine the presence of donor cellmtDNA in SCNT embryos and
offspring, single-nucleotide polymorphisms were analyzed using High
Resolution Melt (HRM). The CYTB regions of the donor cells (Hol-
stein) and recipient oocytes (Angus) were amplified and sequenced.
The CYTB sequences were aligned usingMultiple Sequence Alignment
(Clustal Omega, EMBL-EBI, http://www.ebi.ac.uk/Tools/msa/clustalo/).
HRM primers were designed from the CYTB region to detect single-
nucleotide polymorphisms in donor cell and oocyte mtDNA. To
generate standards for HRM, the purified CYTB PCR products were
ligated into the pCR2.1 vector (Invitrogen, Carlsbad, CA). The ligated
product was transformed into chemically competent cells (Max Effi-
ciency DH5a, Invitrogen) by standard heat-shock transformation.
Positive clones were selected by blue-white selection on LB agar plates
containing 100 mg/ml ampicillin and 40 mg/ml 5-bromo-4-chloro-
3-indolyl-b-D-galactopyranoside (X-gal). White colonies were cul-
tured in LB broth containing 100 mg/ml ampicillin at 37,
200 rpm for 16 hr. Plasmid preparation was performed using the
ISOLATE II Plasmid Mini Kit (Bioline), according to the manufac-
turer’s instructions. To confirm the colonies were positive, the plas-
mids were amplified by PCR using M13F and M13R primers. The
purified PCR products were sequenced by Capillary Electrophoresis
using the ABI PRISM BigDye Terminator Cycle Sequencing Ready
Reaction Kit (Applied Biosystems, Foster City, CA) on an ABI 3130xl
Genetic Analyzer (Applied Biosystems, Hitachi, Tokyo, Japan) by the
Monash Health Translation Precinct Biomedical Genomics Facility
(Clayton, VIC, Australia). The plasmid mixtures of donor cell and
recipient oocyte were prepared to the ratios of 100:0, 50:50, 30:70,
10:90, 3:97, 1:99, and 0:100. Total DNA was extracted from embryos
at the blastocyst stage (five individual embryos per group) using the
QIAamp DNA Micro Kit, according to the manufacturer’s instruc-
tions. The CYTB region was amplified by PCR. Ten microliter re-
action mixtures consisted of 10 ng DNA sample or 10 ng plasmid
mixture, 1· HRM master mix (TrendBio, Melbourne, VIC, Aus-
tralia), 0.25 mM of each primer, as listed in Table S1. The amplifica-
tion conditions were as follows: 95 for 2 min followed by 45 cycles of
94 for 30 sec and 61 for 30 sec. The final step was 94 for 30 sec.
Each standard and sample were analyzed in triplicate. The single-
nucleotide polymorphism in the PCR reaction was analyzed by the
LightScanner system (Idaho Technology Inc., Salt Lake City, UT).
RNA sequencing and analysis
RNA extraction from single blastocysts (three individual embryos per
group) was performed using the Arcturus PicoPure RNA Isolation Kit
(Life Technologies), according to the manufacturer’s instructions. Li-
brary preparations for RNA sequencing were performed using the
Ovation RNA-Seq System V2 (NuGen, San Carlos, CA), according to
the manufacturer’s instructions. First strand cDNA synthesis was per-
formed using a DNA/RNA chimeric primer with random and polyT
sequences. Second strand cDNA was synthesized by DNA polymerase,
which primed at fragmentation of the RNA within the DNA/RNA
complex. After that, the double-stranded cDNAwas amplified by single
primer isothermal amplification. Libraries were quantified using a
Qubit fluorometer and an Agilent 2100 Bioanalyzer (Agilent Technol-
ogy, Santa Clara, CA), and quantitative real time PCR. The denaturated
cDNA (12 pM) was used for c-bot hybridization followed by on-board
cluster generation in two lanes of an Illumina HiSequation 1500 Rapid
with 50 bp read length, according to the manufacturer’s instructions
(Illumina, San Diego, CA) by the Monash Health Translation Precinct
(MHTP) Biomedical Genomics Facility. Raw reads from the libraries
were quality checked using the FastQC tool (http://www.bioinformatics.
babraham.ac.uk/projects/fastqc/). Sequence reads were assembled and
mapped to the bovine reference genome (B. taurus, bosTau7) using
the STAR software (Dobin et al. 2013). The number of reads mapped
to each gene was calculated using the featureCounts tool (Liao et al.
2014). Those raw read counts were used for differential expression
analysis. edgeR (Robinson et al. 2010) was used to analyze the differ-
ential expression of genes by pairwise comparisons between treat-
ment groups. Multiple testing correction was performed in edgeR
(empirical Bayes estimation) by applying the Benjamini and Hoch-
berg method (Benjamini and Hochberg 1995) to P-values, to control
for false-discovery rate (FDR). Differentially expressed genes with an
FDR ,0.05 were considered as significantly different (Driver et al.
2012; Schurch et al. 2016). Pathway analysis was performed using
Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City, CA,
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www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis/),
as described in Cagnone et al. (2016).
Gene expression analysis
RNA extraction from single blastocysts (three individual embryos per
group) was performed using the Arcturus PicoPure RNA Isolation Kit.
cDNA synthesis was undertaken using the qScript Flex cDNA Kit
(Quanta Biosciences, Gaithersburg, MD), according to the manufac-
turer’s instructions. Quantitative real-time PCR was performed using
primer sets shown in Table S1 on a Rotorgene 3000 real-time machine
with SensiMix SYBR Hi-ROX with the following thermal cycling con-
ditions: 95 for 15 min, followed by 45 cycles of 95 for 15 sec, 55 (for
DNMT1 andHDAC) or 56 (forNANOG, SOX2,CDX2,DNMT3a, and
DNMT3b), or 58 (for ACTB, OCT4, TFAM, and POLGA) for 15 sec
and 72 for 15 sec. The final elongation step was performed at 72 for
15 sec. The second extension phase was set at 75 (for TFAM) or 78
(for ACTB and POLGA) or 80 (for HDAC, OCT4, NANOG, DNMT1,
andDNMT3b) or 85 (for SOX2,CDX2, andDNMT3a) for 15 sec, and
the second fluorescence signals were acquired. The relative quantifica-
tion of gene expression was performed using the method described
previously (Livak and Schmittgen 2001). ACTBwas used as an internal
standard for the analysis of relative transcript levels of each gene.
Comparative genomic hybridization microarray
Todetermine the integrity of the genomes of depleted cells, comparative
genomic hybridization (CGH) microarray was performed using the
SurePrint G3 Bovine Genome CGH Microarray Kit (Agilent Technol-
ogies). DNA digestion, labeling, and hybridization were performed
according to the manufacturer’s instructions. Briefly, DNA was extracted
from depleted (n = 3) and nondepleted (n = 3) cells using the
ISOLATE II Genomic DNA Kit, as previously described. DNA con-
centration and quality were measured using a NanoDrop ND-1000
Spectrophotometer (Thermo Scientific, Wilmington, DE); 500 ng of
genomicDNA from depleted and nondepleted cells were digested using
the SureTag DNA Labeling kit (Agilent Technologies), and were fluo-
rescently labeled with Cy5 (for depleted cells) and Cy3 (for nondepleted
cells, the reference). Following purification with the SureTag Purifica-
tion Columns Kit (Agilent Technologies), the labeled samples were
hybridized together at 65 on the microarray for 24 hr in a rotating
Agilent hybridization oven at 20 rpm. Themicroarray was washed and
scanned immediately at 3 mm resolution on a DNA microarray scan-
ner (Agilent Technologies). Data were extracted from the scanned
image using with Feature Extraction Software 11.0.1.1 (Agilent Tech-
nologies). Microarray data were analyzed using the Agilent Genomic
Workbench version 7.0 software (Agilent Technologies), according to
the manufacturer’s instructions. Aberration analysis was performed
using the Aberration Detection Method 2 (ADM-2) algorithm, with
a threshold of six and fuzzy zero turned on. Copy number variation was
defined as absolute log2 ratio for duplication or deletion $0.25
and minimum number of probes = 3 (please refer to File S1).
Statistical analysis
Statistical analysis of mtDNA copy number data was evaluated by one-
way ANOVA with Tukey’s multiple comparisons test using GraphPad
Prism version 6.01 (GraphPad Software Inc., La Jolla, CA). Data for
preimplantation development, cell number, and gene expression were
analyzed by ANOVA, andmeans were compared using Duncan’s Mul-
tiple Range Test using Statistical Analysis System version 9 (SAS Inst.
Inc., Cary, NC). The number of differentially expressed genes was
analyzed using edgeR (Robinson et al. 2010) at FDR ,0.05.
Data availability
RNA-sequencing data for SCNT embryos are deposited at the Sequence
Read Archive, with SRA accession number: SRP078663. CGH micro-
arraydata ofmtDNAdepleted andnondepletedcells aredeposited at the
Gene Expression Omnibus with GEO accession number: GSE97912.
RESULTS
MtDNA depletion of donor cells
As the presence of donor cell and recipient oocyte mtDNA can be
detrimental to development, we depleted fibroblasts derived from a B.
taurus Holstein cow to be used as donor cells for SCNT. We depleted
these cells over 30 d using the mtDNA depletion agent, ddC (20 mM)
to monitor rates of depletion. There were significant decreases in
mtDNA copy number from day 0 (150.11 6 12.21, mean 6 SEM)
to day 30 (0.85 6 0.02) of treatment (P , 0.0001, Figure 1), which
resulted in ,1 copy of mtDNA being present per cell. When cells
depleted for 3, 7, 10, 14, 21, and 30 d were allowed to recover their
mtDNA over 14 d in the absence of ddC, there were no significant
differences in mtDNA copy number between cells depleted for 30 d,
and those allowed to recover for 14 d in the absence of ddC
(4.67 6 0.19) indicating that they had lost their potential to replenish
their mtDNA content. However, cells depleted for shorter periods of
time replenished their mtDNA and exhibited significant differences
compared to their respective depleted levels. Consequently, as cells
depleted for 30 d do not have the capacity to replenish their own
mtDNA, these cells were used as mtDNA depleted donor cells for
SCNT.
Wealsodetermined the effects ofmtDNAdepletiononchromosome
stability of the donor cells by using a CGH microarray. The results
showed that there were no duplications or deletions for the chromo-
somes ofmtDNAdepleted cells when comparedwith nondepleted cells.
This finding revealed that depletingmtDNA through the use of ddC did
not have an adverse effect on chromosome stability in the donor cells.
SCNT embryo production
To determine if depleted cells would be suitable candidates for SCNT,
depleted and nondepleted donor cells were fused toMII oocytes.While
the fusion rates (76.5%) were significantly lower than for nondepleted
cells (93.7%, P , 0.05; Table 1), there was no significant difference
in cleavage rates for embryos derived from depleted (78.7%) and
Figure 1 MtDNA copy number in cells following depletion for 3, 7, 10,
14, 21, and 30 d (D) with ddC, and a recovery period of 14 d (+R).
Mean values (6SEM) are shown. The differences were analyzed for
significance by one-way ANOVA with Tukey’s multiple comparisons
test using GraphPad Prism version 6.01. P , 0.0001.
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nondepleted (87.1%) cells. However, the eight-cell, morula, and blas-
tocyst rates for embryos derived from depleted cells (44.3, 20.7, and
20.1%, respectively) were significantly lower than those from nonde-
pleted cells (61.3, 36.7, and 35.9%, respectively), which suggests that
they were unable to overcome the developmental block associated with
the activation of the embryonic genome (Memili et al. 1998).
Todeterminewhetherassisting theprocessof reprogrammingwould
enhance development of embryos derived from depleted and non-
depleted cells, we cultured reconstructed oocytes in the presence of
TSA for 10 hr. The fusion and cleavage rates for embryos derived from
depleted cells cultured in the presence of TSA (75.2 and 88.3%, re-
spectively) were not significantly different when compared to those
of embryos cultured in the absence of TSA (76.5 and 78.7%, respec-
tively). Importantly, the presence of TSA promoted development
through the developmental block associated with activation of the em-
bryonic genome in SCNT embryos. Consequently, the eight-cell, mor-
ula, and blastocyst rates for embryos derived from depleted cells
cultured in the presence of TSA (60.1, 35.6, and 35.0%, respectively)
were significantly increased when compared to those of embryos
cultured in the absence of TSA (44.3, 20.7, and 20.1%, respectively,
P , 0.05). Furthermore, the morula and blastocyst rates matched
those of embryos derived from nondepleted cells cultured in the pres-
ence and absence of TSA. Consequently, TSA enhanced development
rates for embryos derived from depleted cells to levels equivalent to that
of nondepleted cells.
To determine if the cell number of SCNT embryos was affected by
each treatment, we analyzed blastocysts at day 7 of culture following
staining with 10 mg/ml Hoechst 33342 (Figure 2A). There were no
significant differences in cell number for blastocysts derived from non-
depleted (114 6 9, mean 6 SEM) and depleted cells (132 6 12,
Figure 2B). Although the presence of TSA increased blastocyst forma-
tion rates for embryos derived from depleted cells, these blastocysts had
significantly fewer cells (91 6 11, P , 0.05) when compared to blas-
tocysts generated from depleted cells cultured in the absence of TSA
(132 6 12). However, TSA had no significant effect on cell number
for blastocysts derived from nondepleted cells (presence of TSA,
103 6 10; absence of TSA, 114 6 9; Figure 2B).
Moreover, we performed a small-scale SCNT study using two
different donor cell lines generated from two other adult Holstein cows
(Holstein Nos. 2 and 3) derived from skin fibroblasts depleted of
mtDNA, as described forHolsteinNo. 1. SCNTembryoswere produced
using these depleted cells cultured in the presence of TSA, as described
for Holstein No. 1. Embryos produced from these cell lines also had the
propensity to develop to the blastocyst stage (Table S2 in File S4),
although their blastocyst rates (12–15%) were lower when compared
with those of Holstein No. 1 (35%). However, as this was a smaller scale
study, for consistency purposes, only SCNT embryos derived from the
donor cells of Holstein No.1 were used for further analysis.
Analysis of the persistence of donor cell mtDNA in
SCNT embryos
In order to determine the extent of the persistence of mtDNA from
donor cells harboring mtDNA, we assessed embryos for mtDNA
content. A total of two out of five SCNT blastocysts derived from
embryos that were cultured in the absence of TSA possessed donor cell
mtDNA at levels of 10 and 30% (Figure 3A). Donor cell mtDNA was
also present in two out of five SCNT blastocysts derived from non-
depleted cells cultured in the presence of TSA at levels of 3% (Figure
3B). However, when depleted cells were used as donor cells, blastocysts
from embryos cultured in the presence and absence of TSA (Figure 3, C
and D) harbored only oocyte mtDNA. As a result, SCNT blastocysts
harboring recipient oocyte mtDNA only were successfully produced
usingmtDNAdepleted donor cells in the presence and absence of TSA.
Analysis of mtDNA copy number in SCNT embryos
As increased mtDNA has been associated with poor implantation rates
and aneuploidy (Fragouli et al. 2015), we assessed mtDNA copy num-
ber in SCNT-derived blastocysts produced using B. taurus recipient
oocytes. MtDNA copy number in blastocysts derived from depleted
cells was not significantly different (382,359.75 6 24,712.21, mean 6
SEM) when compared with blastocysts from nondepleted cells
(442,849.57 6 16,509.73; Figure 4A). The presence of TSA had no
significant effect on mtDNA copy number in SCNT blastocysts derived
from depleted or nondepleted cells. However, mtDNA copy number
for blastocysts derived from nondepleted cells cultured in the presence
of TSA (544,364.12 6 76,550.04) was significantly higher than that of
blastocysts derived from depleted cells cultured in the presence of TSA
(334,908.98 6 31,807.74, P , 0.01). Furthermore, no significant
difference was found in mtDNA copy number of SCNT embryos
when compared with parthenogenetically activated (PA) embryos
(426,203.31 6 16,435.08). Moreover, when we assessed mtDNA copy
number per cell at the blastocyst stage, depleting donor cells of mtDNA
or their treatment with TSA had no significant effect on mtDNA copy
number per cell (Figure 4B). However, mtDNA copy number per cell
for embryos derived from nondepleted cells cultured in the presence of
TSAwas significantly higher than for blastocysts derived from depleted
cells cultured in the presence and absence of TSA (Figure 4B).
Notably, mtDNA copy number for embryos at the blastocyst
stage derived from depleted cells cultured in the presence
(334,908.98 6 31,807.74) or absence of TSA (382,359.75 6 24,712.21)
was significantly higher than that of oocytes at the MII stage
(240,064.46 6 8,153.74, P , 0.05 and P , 0.001, respectively, Figure
S1A), as was the case for embryos derived from nondepleted cells (Figure
S1B). These outcomes suggest that embryos derived from depleted cells
have the potential to effectively regulate theirmtDNAcopy number during
preimplantation development.
n Table 1 Developmental potential of cattle embryos derived from mtDNA depleted and nondepleted Holstein donor cells, and B. taurus
recipient oocytes in the presence and absence of TSA
Donor Cell TSA Fused (%) No. Embryos Cleaved (%)a
No. (%) Embryo Developed toa
8-Cell Morulae Blastocysts
Nondepleted 2 254/271 (93.7 6 1.6) b 248 216 (87.1 6 0.3) b,c 152 (61.3 6 2.2) b 91 (36.7 6 2.9) b 89 (35.9 6 3.4) b
+ 201/216 (93.1 6 1.2) b 193 177 (91.7 6 3.2) b 112 (58.0 6 4.8) b,c 72 (37.3 6 1.0) b 72 (37.3 6 1.0) b
Depleted 2 189/247 (76.5 6 1.7) c 174 137 (78.7 6 5.0) c 77 (44.3 6 4.6) c 36 (20.7 6 3.4) c 35 (20.1 6 3.8) c
+ 173/230 (75.2 6 3.1) c 163 144 (88.3 6 3.6) b,c 98 (60.1 6 6.6) b 58 (35.6 6 5.0) b 57 (35.0 6 4.6) b
Values are mean 6 SEM. Four replicates. All experiments were run in parallel. Different lower case letters (b and c) within a column indicate significant differences
(P , 0.05, ANOVA with Duncan’s multiple range test using SAS version 9). 2, absence of TSA; +, presence of TSA.
a
Percentages calculated from the number of embryos that cleaved and developed to each stage.
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Differentially expressed gene analysis in SCNT embryos
In order to determine whether restricting themtDNA content of SCNT
embryos to that of the recipient oocyte’s affects gene expression patterns
at the blastocyst stage, we analyzed single embryos by RNA next gen-
eration sequencing. The number of genes expressed in each blastocyst
was 8740 6 56 (mean 6 SEM) for blastocysts derived from nonde-
pleted cells, 8816 6 102 for blastocysts derived fromnondepleted cells
cultured in the presence of TSA, 8768 6 99 for blastocysts derived
from depleted cells, and 8821 6 107 for blastocysts derived from de-
pleted cells cultured in the presence of TSA. There was no significant
difference in the number of genes expressed among each group.
The dendrogram generated for sample to sample distances (Figure
5A), principle component analysis (Figure 5B), and the heat map of the
1000 most highly expressed genes (Figure 5C) showed that blastocysts
were not necessarily grouped according to their treatment groups.
However, the blastocysts derived from depleted cells and cultured in
the presence of TSA clustered more closely together than the other
groups. We used EdgeR to identify differentially expressed genes
(DEGs) between each of the groups (cut-off level, FDR , 0.05). For
the comparison between blastocysts derived from depleted cells cul-
tured in the presence and absence of TSA, six genes were differentially
expressed (FDR , 0.05). The presence of TSA resulted in decreased
levels of gene expression for NGFR, RASSF5, and KANK2, while there
were increased levels in expression for TMEM38A, CLDN8, and
FREM1 in embryos derived from just depleted cells (Figure 6A and
Table S3 in File S4). For blastocysts derived from nondepleted cells
cultured in the absence of TSA, compared with blastocysts derived
from depleted cells cultured in the presence of TSA, eight out of
10 DEGs were upregulated. However, REV3L and LOC615263 were
downregulated for embryos derived from nondepleted cells (Figure
6B and Table S4 in File S4). Comparing blastocysts derived from de-
pleted and nondepleted cells both cultured in the absence of TSA,
LOC615263, C15H11orf34, and REV3L were upregulated for embryos
from depleted cells while 11 other genes were downregulated (Figure
6C and Table S5 in File S4).
The comparison between blastocysts derived from depleted cells
cultured in the presence of TSA and blastocysts from nondepleted cells
cultured in the presence of TSAproduced 35DEGs (Table S6 in File S4).
However, in this instance, the blastocysts generated from depleted cells
clustered more closely together than the blastocysts from nondepleted
cells (Figure 6D). Notably, ADCY1, CHN2, and GLDC, which are in-
volved in DNA replication and repair and nucleic acid metabolism,
were upregulated for embryos derived from depleted cells cultured in
the presence of TSA (Figure 6D and Table S6). Indeed, the use of
Ingenuity Pathway Analysis (IPA), where 34 out of 35 DEGs were
annotated and clustered into four networks, highlighted the effects
on DNA replication and repair and nucleic acid metabolism, as com-
bined with small molecule biochemistry, this was the most affected
network {IPA score, [2log(P-value)] = 43, Table S7 in File S4}. How-
ever, no upstream regulators were significantly activated (File S2).
Furthermore, there were 66 DEGs from the comparison between
blastocysts from nondepleted cells cultured in the presence of TSA, and
blastocysts derived from depleted cells cultured in the absence of TSA
(Table S8 in File S4). The top 10 most significant DEGs are listed in
Table 2. Indeed, 11 genes involved in cellular function and mainte-
nance, molecular transport, and cell-to-cell signaling and interaction
(CA4, CLDN3, CLDN8, ENTPD1, FUT8, GRM1, LRRC59, P2RY2,
RAP2C, SLC34A2, and SLC9A3) were upregulated in blastocysts
Figure 2 Assessment of SCNT embryos. (A) Fluo-
rescence images of SCNT embryos at the blastocyst
stage stained with Hoechst 33342: (1) embryos
derived from nondepleted cells in the absence of
TSA; (2) embryos derived from nondepleted cells in
the presence of TSA; (3) embryos derived from
depleted cells in the absence of TSA; and (4)
embryos derived from depleted cells in the pres-
ence of TSA. (B) Cell number in SCNT embryos at
the blastocyst stage (n = 3/group). Mean values
(6SEM) are shown. Different superscripts within a
column indicate significant differences (P , 0.05,
ANOVA with Duncan’s multiple range test).
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derived from nondepleted cells cultured in the presence of TSA (Figure
6E and Table S8). Again, the use of IPA annotated and clustered 63 out
of the 66 DEGs into six networks, demonstrating that cellular function
and maintenance, molecular transport, and cell-to-cell signaling and
interaction was the most affected network (IPA score = 49, Table S9 in
File S4). The predicted upstream regulators that were activated in-
cluded ENPP3, LIMCH1, NDRG1, SHISA2, and TIMP2, which are in-
volved in the pathway modulating ligand-dependent nuclear receptor,
estrogen receptor 2 (ESR2, File S3). Interestingly, no significant DEGs
were identified for blastocysts derived from nondepleted cells cultured
in the presence and absence of TSA.
The Venn diagram in Figure 7 shows the number of overlapping
DEGs in SCNT embryos, which are documented in Table 3. There were
no commonly DEGs among the five comparison groups. Interestingly,
depletion of donor cell mtDNA affected the expression levels of REV3L,
ADAM19, CA4, FKBP9, HERC3, USP3, ZADH2, ADCY1, APOA1,
CLDN10, DNASE1L3, ENPP3, ENTPD1, EXOC6B, INO80E, SHISA2,
and P2RY2, which are associated with the cell cycle, cell-to-cell signal-
ing and interaction, and cellular growth and proliferation network. The
combination of depleted donor cells, and the presence of TSA affected
expression of genes (NGFR, KANK2, CD74,NID1, andUPP1) involved
in the cell-to-cell signaling and interaction, hematological system
development and function, and immune cell trafficking networks.
Moreover, the presence of TSA in embryos derived from depleted
cells positively modulated the expression patterns of CLDN8 and
TMEM38A (Table 4).
As the compartmentalization of the inner cell mass and trophecto-
derm is essential to blastocyst formation, we assessed each group for the
expression of the transcription factors associated with maintaining the
inner cell mass (OCT4, SOX2, and NANOG) and establishing the tro-
phectoderm (CDX2) by real time PCR. There was subtle variability
among each set of blastocysts, with fold changes,2. However, expres-
sion levels for blastocysts generated from depleted cells in the presence
of TSA were closer to blastocysts derived from nondepleted cells in the
Figure 3 HRM analysis of CYTB PCR products
from SCNT embryos. The different fluorescence
curves were plotted by LightScanner HRM analy-
sis software (Version 2.0). The dilutions of plas-
mids that carry PCR fragments at the ratio of
donor cell:recipient oocyte of 50:50, 30:70,
10:90, 3:97, 1:99, and 0:100 are indicated by or-
ange, blue, red, green, purple, and pink lines,
respectively. SCNT embryos at the blastocyst
stage are indicated in gray (n = 5/group). Each
standard and sample were analyzed in triplicate.
The different curves that overlap with or are be-
low the pink line are considered to harbor only
oocyte mtDNA. (A) Embryos derived from non-
depleted cells. Two out of five embryos pos-
sessed donor cell mtDNA at levels of 10 and
30%, and are indicated by the black and red ar-
rows, respectively. (B) Embryos derived from non-
depleted cells in the presence of TSA. Two out of
five embryos possessed donor cell mtDNA at lev-
els of 3%, and are indicated by the blue arrow. (C)
Embryos derived from depleted cells. All em-
bryos harbored only oocyte mtDNA. (D) Embryos
derived from depleted cells in the presence of
TSA. All embryos harbored only oocyte mtDNA.
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presence of TSA than for blastocysts generated from depleted and non-
depleted cells in the absence of TSA. There were similar outcomes
for the modulators of DNA demethylation, namely DNMT1 and
DNMT3a. However, there were no differences for DNMT3b and a
marginal difference forHDAC. In terms of the key mtDNA replication
factors, again, blastocysts from nondepleted cells cultured in the ab-
sence of TSA exhibited significantly higher levels of expression of mi-
tochondrial transcription factor A (TFAM). The late expression (cycle
number 43–45) of DNA Polymerase Gamma A (POLGA) reflects con-
trolled levels of mtDNA replication (Figure 8). Overall, blastocysts
generated from depleted cells cultured in the presence of TSA exhibited
a more consistent pattern of gene expression for key regulators of early
development.
DISCUSSION
To the best of our knowledge, this is the first report of the use of ddC to
deplete donor cells of their mtDNA prior to SCNT. Ethidium bromide
hasbeenused todepletemtDNAfromdonor cells togenerateboth sheep
and goat-sheep embryos (Lloyd et al. 2006) and sheep offspring (Lee
et al. 2010). However, ethidium bromide is highly toxic as a mutagen,
and also a possible carcinogen or teratogenic (Waring 1965). The nu-
cleoside reverse transcriptase inhibitor, ddC, has been used widely to
suppress HIV replication, and affects the interaction of POLG with the
mitochondrial genome (Brinkman and Kakuda 2000). The actions of
ddC are more specific as an inhibitor of mtDNA replication than its
counterpart ethidium bromide (Brown and Clayton 2002), as it binds
specifically to POLG, which effects only replication of mtDNA, and not
the nuclear DNA polymerases, namely DNA polymerase alpha, delta,
and epsilon (reviewed by Brinkman et al. (1998)). Therefore, ddC was
chosen to deplete mtDNA from donor cells.
However, as a note of caution, previous reports have shown that ddC
can decrease cellular lipids, increase apoptosis, and induce mitochon-
drial depolarization (Walker et al. 2006). Moreover, as loss of function
in the mitochondrial electron transport chain in mtDNA depleted cells
can inhibit the de novo synthesis of pyrimidines, resulting in these cells
failing to proliferate (King and Attardi 1989), it is important to add
substrates such as uridine to the culture medium to ensure sufficient
pyrimidines are produced (Grégoire et al. 1984). Indeed, uridine is used
frequently in mtDNA depletion experiments in respect of both ethi-
dium bromide (Lloyd et al. 2006; Lee et al. 2010) and ddC (Keilbaugh
et al. 1993; Nelson et al. 1997). Nevertheless, mtDNA-depleted cells
continue to have lower proliferation rates in the presence of uridine
(Lloyd et al. 2006; Bowles et al. 2007), which is advantageous, as re-
duced cell proliferation in donor cells is normally mediated through
serum starvation prior to SCNT in order that they are synchronized to
the G0/G1 phase (Campbell et al. 1996; Wilmut et al. 1997). Further-
more, from our CGH microarray results, it is evident that depleting
donor cells of their mtDNA, by culturing in ddC with uridine for 30 d,
does not alter their chromosomal stability.
The use ofmtDNAdepleted cells as donor cells for SCNT resulted in
all embryos harboring only oocyte mtDNA, as is the case following
sperm-mediated fertilization (Sato and Sato 2012). However, the mix-
ing of two populations of mtDNA, namely from the donor cell and the
recipient oocyte, was identified in embryos derived from nondepleted
cells at levels ranging from 0 to 30% for donor cell mtDNA. Notably,
replication of donor cell mtDNA represented a 0- to 886-fold increase
from the amount introduced into the recipient oocyte for SCNT blas-
tocysts derived from nondepleted cells. This demonstrates the random
nature of the transmission of donor cell mtDNA if cells are not de-
pleted. As a previous report has shown, SCNT embryos produced by
donor cells harboring a full complement ofmtDNA, orwere partially or
almost completely depleted of mtDNA also possessed two populations
of mtDNA (Lloyd et al. 2006), demonstrating that even low levels of
mtDNA can be transmitted. These somatic cell mitochondria are likely
to be detrimental to development as demonstrated by the introduction
of somatic cell mitochondrial isolates into mouse oocytes (Takeda et al.
2005, 2012). Furthermore, there is a considerable beneficial effect from
using depleted cells as donor cells since cell number in SCNT blasto-
cysts was increased when using partially depleted cells (Lloyd et al.
Figure 4 MtDNA copy number in SCNT embryos at the blastocyst
stage. (A) mtDNA copy number per embryo. Mean values (6SEM) are
shown. The differences were analyzed for significance by one-way
ANOVA with Tukey’s multiple comparisons test using GraphPad Prism
version 6.01. P , 0.01. (B) mtDNA copy number per cell. Mean val-
ues (6SEM) are shown. The differences were analyzed for significance
by one-way ANOVA with Tukey’s multiple comparisons test using
GraphPad Prism version 6.01. P , 0.05, P , 0.001, respectively.
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2006; Lee et al. 2010), as is the case for our cattle embryos. In addition,
mtDNA depletion results in an increase in the rates of pregnant females
and live born offspring in sheep (Lee et al. 2010). These outcomes
demonstrate the importance of depleting donor cells to promote de-
velopmental outcomes, and to ensure that the resultant offspring in-
herit their mtDNA in a true maternal manner.
TSA increased developmental rates to the blastocyst stage for
embryos derived from depleted cells to levels equivalent to that of
nondepleted cells. However, no beneficial effects were observed for
the embryos derived from nondepleted cells. Several reports show that
the effect of TSA on embryo development is controversial in different
species (Monteiro et al. 2010), and tends to be dependent on donor cell
type (Kishigami et al. 2006; Martinez-Diaz et al. 2010). However, to
date, there has been no report of the use of TSA on embryos derived
from mtDNA-depleted cells. A previous report in sheep showed that
two live offspring were successfully produced by using mtDNA-
depleted cells as the donor cells for SCNT (Lee et al. 2010). Although
Lee et al. (2010) used a different depletion reagent (ethidium bromide)
to that used in this study, they showed that embryos derived from
depleted cells can develop to term and result in viable lambs. The effects
of TSA on pre- and postimplantation development of embryos are still
debatable. Although previous reports have shown that TSA had
Figure 5 Global gene expression profiles of SCNT blastocysts. (A) A dendrogram generated from sample to sample distances. (B) Principle
component analysis plot; individual blastocysts (n = 3/group) derived from nondepleted cells (green), nondepleted cells in the presence of TSA
(blue), depleted cells (black), and depleted cells in the presence of TSA (red) are numbered. (C) Heat map of the 1000 most highly expressed
genes, showing the correlations among each group of blastocysts. These blastocysts do not group according to their treatment.
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detrimental effects on embryo development (Tsuji et al. 2009) and the
health of the offspring (Meng et al. 2009; Zhao et al. 2010), healthy live
offspring derived from SCNT embryos cultured in the presence of
TSA have been produced successfully in many species such as mice
(Kishigami et al. 2006, 2007), cattle (Sawai et al. 2012; Srirattana et al.
2012), and pigs (Li et al. 2008). Taken together, there is the potential to
generate live offspring from the combination of mtDNA-depleted cells
and TSA supplementation.
Normally, mtDNA replication does not take place in embryos until
the blastocyst stage (May-Panloup et al. 2005; Spikings et al. 2007).
Therefore, transferring mtDNA depleted cells does not have negative
effects in term of mtDNA copy number in oocytes. Moreover, these
embryos have the potential to effectively regulate their mtDNA copy
number, as the mtDNA copy number in blastocysts derived from de-
pleted cells was 1.5 times higher when compared with that of MII
oocytes. Depleting mtDNA from donor cells also has a beneficial effect
on controlling the level of mtDNA copy number in blastocysts, as the
blastocysts derived from depleted cells maintained their mtDNA copy
number at a level that is within range for postimplantation develop-
ment. However, mtDNA copy number per cell in blastocysts derived
from nondepleted cells in the presence of TSA was significantly higher
than that for depleted cells cultured in the presence and absence of TSA.
Notably, human fertilized blastocysts that have a higher mtDNA copy
number than the relative cut-off threshold are more prone to aneu-
ploidy (Fragouli et al. 2015), and lower viability and implantation rates
(Diez-Juan et al. 2015).
Our RNA-sequencing data produced a small number of genes that
were differentially expressed among each of the comparisons (cut-off
level, FDR , 0.05). However, this finding revealed that depleting
mtDNA from donor cells prior to SCNT and culture in the presence
of TSA after SCNT changed the expression profiles of the resultant
embryos. Depleting donor cell mtDNA prior to SCNT affects
Figure 6 DEGs in SCNT embryos at the blasto-
cyst stage. Heat map of differentially expressed
genes between: (A) blastocysts derived from de-
pleted cells in the presence and absence of TSA;
(B) blastocysts derived from nondepleted cells in
the absence of TSA and blastocysts derived from
depleted cells in the presence of TSA; (C)
blastocysts derived from nondepleted and de-
pleted cells in the absence of TSA; (D) blastocysts
derived from nondepleted and depleted cells in
the presence of TSA; and (E) blastocysts derived
from nondepleted cells in the presence of TSA,
and blastocysts derived from depleted cells in the
absence of TSA.
2074 | K. Srirattana and J. C. St. John
expression patterns of genes associated with cell death and survival in
SCNT embryos at the blastocyst stage. Interestingly, REV3L, which is
involved in the DNA repair process, was upregulated in embryos de-
rived from depleted cells. Loss of REV3L causes chromosomal instabil-
ity, and failure of embryogenesis in mouse (Lange et al. 2016). The
presence of TSA positively modulated the expression levels of CLDN8,
TMEM38A, and FREM1 in embryos derived from depleted cells.
CLDN8 is one of the Claudin family of tight junction membrane pro-
teins, which play important roles in maintaining blastocoel shape
though hydrostatic pressure. Removal of Claudins from the trophecto-
derm of mouse embryos causes collapsing of the blastocyst and disrup-
tion of embryonic development (Moriwaki et al. 2007). TMEM38A,
also known as trimeric intracellular cation channel (TRIC) type A, is
a monovalent cation channel that is required for maintenance of rapid
intracellular calcium release. Double knockout mice lacking TRIC sub-
type A and B exhibited cardiac problems, leading to embryonic lethal-
ity at embryonic day 10.5 (Yazawa et al. 2007). Moreover, FREM1 is
generally expressed in the developing embryo, and is essential for the
normal adhesion of the embryonic epidermis (Smyth et al. 2004).
Therefore, TSA has beneficial effects on embryos derived from depleted
cells in terms of increasing expression levels of genes involved in em-
bryo development. Moreover, blastocysts derived from depleted cells
cultured in the presence of TSA exhibited different gene expression
profiles, and are clustered more closely together than blastocysts de-
rived from nondepleted cells in the presence of TSA. However, blasto-
cysts derived from nondepleted cells in the presence of TSA had a
higher mtDNA copy number and possessed donor cell mtDNA. These
two differences are likely to be the mediators of the changes in gene
expression as they are the only two anomalies between the two cohorts.
The 66 DEGs from the comparison between embryos derived from
nondepleted cells in the presence of TSA, and from depleted cells in the
absence of TSA, showed that these two sets of blastocysts were very
different. These results correlated with the significant differences in
mtDNA copy number per cell in blastocysts and levels of expression of
OCT4 and CDX2 from real-time RT-PCR. Notably, two DEGs,
FAM115C and SLC16A7, which have been reported to be key genes
expressed in cattle in vivo-derived embryos at the blastocyst stage (Jiang
et al. 2014), were upregulated in embryos derived from nondepleted
cells in the presence of TSA. Upstream regulator analysis showed
that ESR2, which plays an important role in embryo development
Figure 7 Venn diagram showing the commonly
differential expressed genes among each com-
parison group. Five comparisons are shown.
There are no commonly expressed genes for all
of the comparison groups.
n Table 2 List of the top 10 most significant DEGs from the comparison between SCNT blastocysts derived from nondepleted cells
cultured in the presence of TSA, and depleted cells cultured in the absence of TSA (n = 66). Fold changes are relative to SCNT blastocysts
derived from depleted cells in the absence of TSA
No. Gene Symbol Gene ID Gene Name Chr Fold Change Regulation FDR Type
1 C2H1orf64 NM_001205359.1 Chromosome 2 open reading frame,
human C1orf64
2 26.52983 Up 0.001904 NA
2 EXOC6B NM_001076416.1 Exocyst complex component 6B 11 2.325931 Up 0.001904 Other
3 ADCY1 NM_174229.2 Adenylate cyclase type 1 4 679.3225 Down 0.001904 Peptidase
4 TGFBI NM_001205402.1 Transforming growth factor beta induced 7 7.94732 Down 0.001904 Other
5 CA4 NM_173897.1 Carbonic anhydrase IV 19 418.4826 Up 0.002735 Enzyme
6 KLK6 NM_001101140.2 Kallikrein related peptidase 6 18 4.195303 Down 0.003356 Peptidase
7 REV3L NM_001206172.1 REV3-like, polymerase (DNA directed),
zeta, catalytic subunit
9 2.357427 Down 0.003356 Enzyme
8 FMR1NB NM_001102262.2 Fragile X mental retardation 1 neighbor X 18.72273 Down 0.003369 Other
9 DNASE1L3 NM_001205724.1 Deoxyribonuclease I-like 3 22 91.94144 Up 0.003886 Enzyme
10 RAP2C NM_001075700.1 RAP2C, member of RAS oncogene family X 2.888357 Up 0.003899 Enzyme
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(Bondesson et al. 2015), was activated in embryos derived from non-
depleted cells in the presence of TSA.
Moreover, ourRNA-sequencingdataprovidednew insightswith the
unannotated genes such as LOC615263 and C15H11orf34 being upre-
gulated in embryos derived from depleted cells. A previous report
showed that expression of LOC615263 was upregulated in cattle em-
bryos at day 13 after the transfer of in vitro-derived blastocysts when
compared with in vivo-derived blastocysts (Clemente et al. 2011).
Other unannotated genes were also identified in this study such as
C10H5orf13, C18H16orf70, and C2H1orf64.
From real time RT-PCR, small fold changes (,2) between each of
the cohorts of embryos showed that the expression patterns of embryos
derived from depleted and nondepleted cells were slightly different. The
expression levels of SOX2,DNMT1, andTFAMwere significantly lower
in embryos derived from depleted cells when compared with nonde-
pleted cells. When focusing on blastocysts derived from depleted cells,
TSA had no effect on OCT4, SOX2, and NANOG, which are key reg-
ulators of the inner cell mass. In support of this, the use of TSA on
donor cells prior to SCNT was shown to have no effect on the expres-
sion of OCT4 and NANOG in cattle SCNT blastocysts (Hosseini et al.
2016). Moreover, the levels of expression of CDX2 and DNMT3a, as
well as cell number in embryos derived from depleted cells, were de-
creased after culture in TSA. Consequently, it appears that TSA appro-
priately modulates the expression profiles of transcription factors
involved in establishing blastocyst formation, especially as the expres-
sion profiles of blastocysts derived from depleted cells cultured in the
presence of TSA were closer to blastocysts derived from nondepleted
cells cultured in the presence of TSA than for any other group.
The results from this study showed that embryos derived from
depleted cells and cultured in the presence of TSA seem to be normal
whencomparedwith that ofnondepleted cells.Asonlyonecell line from
an individual cow was used to undertake all the work in the current
investigations, the effects ofmtDNAdepletion in SCNT embryosmight
be cell line specific. However, we were able to determine that two other
cell lines were also competent for generating blastocyst stage embryos.
Nevertheless, the effects of mtDNA depletion on other cell lines would
Figure 8 Real time PCR to determine levels of expression of genes involved in pluripotency and differentiation, epigenetic regulation, and
mtDNA replication in SCNT-derived blastocysts. Values represent mean 6 SEM; n = 3/group. Different superscripts within a column indicate
significant differences (P , 0.05, ANOVA with Duncan’s multiple range test).
n Table 4 List of genes affected by donor cell mtDNA depletion and the presence of TSA
Treatment Gene List
Depleted cells REV3L, ADAM19, CA4, LOC615263, C15H11orf34, FKBP9, HERC3,
USP3, ZADH2, ADCY1, APOA1, CLDN10, DNASE1L3, ENPP3,
ENTPD1, EXOC6B, FMR1NB, INO80E, P2RY2, SHISA2
Depleted cells and TSA treatment NGFR, KANK2, CD74, NID1, UPP1
TSA treatment CLDN8, TMEM38A
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need tobe compared in termsof the outcomes related togene expression
changes.
In conclusion, depletingmtDNAfrom the donor cells prior to SCNT
has beneficial effects in terms of SCNT embryos inheriting only one
population of mtDNA, namely from their oocytes. This increases cell
number and controls mtDNA copy number at the blastocyst stage.
Analyses of DEGs showed that the expression patterns of blastocysts
derived from depleted cells were different to that of nondepleted cells.
Based on network analysis, the DEGs between these two groups of
embryoswereprimarily involved in embryonicdevelopment.Moreover,
the presence of TSA significantly enhanced blastocyst formation rates
for embryos derived from depleted cells, which positively modulated
expression patterns of genes associated with the inner cell mass and
DNA methylation, as well as embryonic development.
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